China NMPA Inspection - Chengdu Weixin Electronic Science and Technology New Technology Co., Ltd. - April 07, 2016

Chengdu Weixin Electronic Technology Co., Ltd. was the subject of an unannounced inspection, the findings of which were detailed in a report published on April 7, 2016. Conducted by the Sichuan Provincial Food and Drug Administration, this inspection aimed to assess the company's adherence to stringent regulatory requirements governing medical device manufacturing. The investigation revealed that Chengdu Weixin Electronic Technology Co., Ltd. was not in compliance with critical aspects of the Good Manufacturing Practice (GMP) for Medical Devices. This regulatory framework is essential for ensuring the quality, safety, and efficacy of medical products throughout their production lifecycle. A primary concern highlighted in the inspection report was the identified deficiencies within the company's quality management system. These shortcomings indicate that the established procedures and controls designed to ensure consistent product quality and regulatory compliance were not adequately implemented or maintained. Consequently, the Sichuan Provincial Food and Drug Administration has issued a directive requiring Chengdu Weixin Electronic Technology Co., Ltd. to undertake prompt and comprehensive corrective actions. The company has been ordered to rectify all identified deficiencies within a specified period to bring its operations into full alignment with the Good Manufacturing Practice for Medical Devices, thereby safeguarding public health and maintaining industry standards.